These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 3510005

  • 21. Characterization of the target cell receptor for IgE. II. Polyacrylamide gel analysis of the surface IgE receptor from normal rat mast cells and from rat basophilic leukemia cells.
    Conrad DH, Froese A.
    J Immunol; 1976 Feb; 116(2):319-26. PubMed ID: 1249417
    [Abstract] [Full Text] [Related]

  • 22. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo.
    He S, Walls AF.
    Br J Pharmacol; 1998 Dec; 125(7):1491-500. PubMed ID: 9884078
    [Abstract] [Full Text] [Related]

  • 23. Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans.
    Sayama S, Iozzo RV, Lazarus GS, Schechter NM.
    J Biol Chem; 1987 May 15; 262(14):6808-15. PubMed ID: 3553192
    [Abstract] [Full Text] [Related]

  • 24. Chymase-directed serine protease inhibitor that reacts with a single 30-kDa granzyme and blocks NK-mediated cytotoxicity.
    Woodard SL, Jackson DS, Abuelyaman AS, Powers JC, Winkler U, Hudig D.
    J Immunol; 1994 Dec 01; 153(11):5016-25. PubMed ID: 7963562
    [Abstract] [Full Text] [Related]

  • 25. Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase.
    Lipitsä T, Naukkarinen A, Laitala J, Harvima IT.
    Arch Dermatol Res; 2016 Oct 01; 308(8):575-84. PubMed ID: 27465068
    [Abstract] [Full Text] [Related]

  • 26. Heparin is essential for the storage of specific granule proteases in mast cells.
    Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, Huang C, Sharpe AH, Stevens RL.
    Nature; 1999 Aug 19; 400(6746):769-72. PubMed ID: 10466726
    [Abstract] [Full Text] [Related]

  • 27. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR.
    Arch Biochem Biophys; 1997 Aug 01; 344(1):133-8. PubMed ID: 9244390
    [Abstract] [Full Text] [Related]

  • 28. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y, Kido H, Kawaji K, Kamoshita K, Katunuma N, Ogura T.
    Arch Biochem Biophys; 1994 Jul 01; 312(1):67-74. PubMed ID: 8031148
    [Abstract] [Full Text] [Related]

  • 29. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.
    Lindstedt L, Lee M, Castro GR, Fruchart JC, Kovanen PT.
    J Clin Invest; 1996 May 15; 97(10):2174-82. PubMed ID: 8636396
    [Abstract] [Full Text] [Related]

  • 30. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
    Glovsky MM, Hugli TE, Ishizaka T, Lichtenstein LM, Erickson BW.
    J Clin Invest; 1979 Sep 15; 64(3):804-11. PubMed ID: 89118
    [Abstract] [Full Text] [Related]

  • 31. Antibodies and inhibitor of chymase are incorporated into mast cell granules and inhibit histamine release.
    Kido H, Fukusen N, Katunuma N.
    Biol Chem Hoppe Seyler; 1988 May 15; 369 Suppl():95-100. PubMed ID: 2462436
    [Abstract] [Full Text] [Related]

  • 32. Cellular receptors to the anaphylatoxins C3a and C5a.
    Huey R, Fukuoka Y, Hoeprich PD, Hugli TE.
    Biochem Soc Symp; 1986 May 15; 51():69-81. PubMed ID: 3545212
    [Abstract] [Full Text] [Related]

  • 33. Uptake of 125I-labelled C3a by cultured human endothelial cells.
    Denney JB, Johnson AR.
    Immunology; 1979 Feb 15; 36(2):169-77. PubMed ID: 437829
    [Abstract] [Full Text] [Related]

  • 34. Mechanism by which heparin proteoglycan modulates mast cell chymase activity.
    Pejler G, Sadler JE.
    Biochemistry; 1999 Sep 14; 38(37):12187-95. PubMed ID: 10508424
    [Abstract] [Full Text] [Related]

  • 35. Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors.
    He SH, Chen P, Chen HQ.
    Acta Pharmacol Sin; 2003 Sep 14; 24(9):923-9. PubMed ID: 12956943
    [Abstract] [Full Text] [Related]

  • 36. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
    Schechter NM, Brass LF, Lavker RM, Jensen PJ.
    J Cell Physiol; 1998 Aug 14; 176(2):365-73. PubMed ID: 9648924
    [Abstract] [Full Text] [Related]

  • 37. Low density lipoprotein degradation by secretory granules of rat mast cells. Sequential degradation of apolipoprotein B by granule chymase and carboxypeptidase A.
    Kokkonen JO, Vartiainen M, Kovanen PT.
    J Biol Chem; 1986 Dec 05; 261(34):16067-72. PubMed ID: 3536921
    [Abstract] [Full Text] [Related]

  • 38. Biological functions of serine proteases in mast cells in allergic inflammation.
    Katunuma N, Kido H.
    J Cell Biochem; 1988 Dec 05; 38(4):291-301. PubMed ID: 2467915
    [Abstract] [Full Text] [Related]

  • 39. Mast cell granule heparin proteoglycan induces lacunae in confluent endothelial cell monolayers.
    Lagunoff D, Rickard A.
    Am J Pathol; 1999 May 05; 154(5):1591-600. PubMed ID: 10329611
    [Abstract] [Full Text] [Related]

  • 40. Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells.
    Nakano A, Kishi F, Minami K, Wakabayashi H, Nakaya Y, Kido H.
    J Immunol; 1997 Aug 15; 159(4):1987-92. PubMed ID: 9257865
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.